In Phase A, contributors will obtain diverse doses and schedules of oral ABBV-744 tablet to establish safe dosing routine. Extra members will likely be enrolled for the recognized monotherapy dosign routine. In Section B, contributors will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In Segment https://abbv-744safetyandsideeffe13467.qodsblog.com/31938520/considerations-to-know-about-is-abbv-744-effective-for-hematologic-cancers